LEAH GRAVES: Open Payments
NPI 1013317825 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,332 in 199 payments from 22 companies in 2025. Trend: 2023 $4,478 · 2024 $4,408 · 2025 $4,332
Food & beverage: $4,332
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $721 |
| PFIZER INC. | 28 | $590 |
| Novartis Pharmaceuticals Corporation | 20 | $572 |
| Amgen Inc. | 27 | $469 |
| UCB, Inc. | 22 | $422 |
| E.R. Squibb & Sons, L.L.C. | 14 | $330 |
| AstraZeneca Pharmaceuticals LP | 10 | $235 |
| GlaxoSmithKline, LLC. | 8 | $172 |
| Radius Health, Inc. | 5 | $128 |
| Mallinckrodt Hospital Products Inc. | 4 | $101 |
Products named: RINVOQ, Bimzelx, XELJANZ, COSENTYX, ORENCIA, SKYRIZI, SAPHNELO, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across AL — which companies pay providers there.
